醫療器材和診斷 業務的一部分 生命科學.
Finnegan與各種規模的創新客戶合作,包括財富100強,全球1000強,以及醫療設備和診斷產業的新創公司。拯救生命,提高病患生活品質,改善醫療保健服務,以及找出侵入性較小的疾病治療方法,是醫療器材產業的首要考量。高度競爭的診斷產業不斷尋求更快,更精準的檢測改良方法,以及研發新方法,以偵測不斷演變的標靶。創新者面臨許多挑戰,包括高度複雜的專利訴訟,利潤緊縮,產品生命週期變短,可能影響產品可行性的補償計劃,以及通常需要經歷漫長臨床試驗的昂貴研發之路。此外,新的器材必須符合美國食品藥品監督管理局的安全和行銷法規,該法規可能要求器材上市之前需公開揭露敏感的設計資訊。為保有競爭力,公司必須保護和執行其所擁有的智財權。
在Finnegan,我們擁有法律經驗和技術專長,可以幫助客戶解決在開發,保護,與商業化醫療器材和診斷發明中出現的許多問題。我們的經驗包括與大公司的內部律師合作,處理申請案,盡職調查,授權,和高風險的訴訟,到為新創公司的管理高層就營運決策提供建議,以幫助公司起步。我們了解醫療器材產業的高度競爭性,投資人和股東創造價值的需求,與智財權及早和強化保護的重要性。我們亦針對保護診斷發明之複雜且不斷變化的專利法規,提供客戶導航之協助。
從確定新產品的競爭環境到擬訂訴訟的制勝策略,我們協助的項目有:
我們與醫療器材客戶合作,內容涉及廣泛的學科和技術,包括:
我們與診斷產業客戶合作,亦橫跨廣泛的學科與技術,包括:
保護創新之全面的法律,技術,和策略經驗
我們的生命科學業務由250多位律師和專業人士組成,致力於滿足客戶對於智財權服務的需求。多數擁有與生物學,化學,生物化學,醫學,藥理學,或生醫工程等相關學科的高階學位。大多具有紮實的研究和/或產業經驗,許多人在產業或大學任職,或在美國專利商標局擔任審查委員後加入Finnegan飛翰。
1:23-cv-00756, D. Del., Judge Williams
1:21-cv-01610, D. Del., Judges Andrews, Hall
Represented Intuitive Surgical Operations on appeals from petitions for inter partes review (IPR) filed by Auris Health, Inc.
21-1473, -1732, -1733, Fed. Cir., Judges Prost, Dyk, Reyna
IPR2019-01173, -01533, -01547, PTAB, Judges Franklin, Hulse, Jenks, Worth, Yang
3:21-cv-16766, D.N.J., Judges Kirsch, Singh
2:19-cv-14240, D.N.J., Judges Martinotti, Dickson
Successfully represented Propel in defending against a preliminary injunction action filed by a competitor for patent infringement on orthodontic devices. The court denied any of the relief requested by the patentee, finding that their asserted patent is likely invalid. On appeal, the Federal Circuit affirmed the district court’s decision.
5:17-cv-03801, N.D. Cal., Judges Davila, Van Keulen, Seeborg
18-1534, Fed. Cir., Judges Prost, Reyna, Wallach
Webinar
Is There a “Right to Repair”? and What Do IP Professionals Need to Know About It?
April 6, 2023
Webinar
Federal Circuit IP Blog
February 23, 2023
Apple Eyes Long-Term Software Fix for Watch While Appealing Ban
December 28, 2023
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.